146 related articles for article (PubMed ID: 19528479)
1. (-)-Gossypol reduces invasiveness in metastatic prostate cancer cells.
Huang YW; Wang LS; Dowd MK; Wan PJ; Lin YC
Anticancer Res; 2009 Jun; 29(6):2179-88. PubMed ID: 19528479
[TBL] [Abstract][Full Text] [Related]
2. The effects of gossypol on the invasiveness of MAT-LyLu cells and MAT-LyLu cells from the metastasized lungs of MAT-LyLu-bearing Copenhagen rats.
Jiang J; Kulp SK; Sugimoto Y; Liu S; Lin YC
Anticancer Res; 2000; 20(6B):4591-7. PubMed ID: 11205308
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
[TBL] [Abstract][Full Text] [Related]
4. Gossypol inhibits the growth of MAT-LyLu prostate cancer cells by modulation of TGFbeta/Akt signaling.
Jiang J; Ye W; Lin YC
Int J Mol Med; 2009 Jul; 24(1):69-75. PubMed ID: 19513537
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.
Jiang J; Sugimoto Y; Liu S; Chang HL; Park KY; Kulp SK; Lin YC
Anticancer Res; 2004; 24(1):91-100. PubMed ID: 15015581
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells.
Huang YW; Wang LS; Chang HL; Ye W; Dowd MK; Wan PJ; Lin YC
Anticancer Res; 2006; 26(3A):1925-33. PubMed ID: 16827126
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.
Powell CT; Gschwend JE; Fair WR; Brittis NJ; Stec D; Huryk R
Cancer Res; 1996 Sep; 56(18):4137-41. PubMed ID: 8797581
[TBL] [Abstract][Full Text] [Related]
8. Can homeopathic treatment slow prostate cancer growth?
Jonas WB; Gaddipati JP; Rajeshkumar NV; Sharma A; Thangapazham RL; Warren J; Singh AK; Ives JA; Olsen C; Mog SR; Maheshwari RK
Integr Cancer Ther; 2006 Dec; 5(4):343-9. PubMed ID: 17101763
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
[TBL] [Abstract][Full Text] [Related]
10. Effects of gossypol on O2 consumption and CO2 production in human prostate cancer cells.
Jiang J; Ghosh PK; Kulp SK; Sugimoto Y; Liu S; Czekajewski J; Chang HL; Lin YC
Anticancer Res; 2002; 22(3):1491-6. PubMed ID: 12168828
[TBL] [Abstract][Full Text] [Related]
11. An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis.
Dandekar DS; Lokeshwar VB; Cevallos-Arellano E; Soloway MS; Lokeshwar BL
Cancer Chemother Pharmacol; 2003 Jul; 52(1):59-66. PubMed ID: 12734674
[TBL] [Abstract][Full Text] [Related]
12. Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility.
Fraser SP; Salvador V; Manning EA; Mizal J; Altun S; Raza M; Berridge RJ; Djamgoz MB
J Cell Physiol; 2003 Jun; 195(3):479-87. PubMed ID: 12704658
[TBL] [Abstract][Full Text] [Related]
13. The effect of castanospermine on the metastatic properties of prostate cancer cells.
Yee CS; Schwab ED; Lehr JE; Quigley M; Pienta KJ
Anticancer Res; 1997; 17(5A):3659-63. PubMed ID: 9413219
[TBL] [Abstract][Full Text] [Related]
14. Differential growth inhibition and induction of apoptosis by gossypol between HCT116 and HCT116/Bax(-/-) colorectal cancer cells.
Zhang M; Liu H; Tian Z; Huang J; Remo M; Li QQ
Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):230-7. PubMed ID: 17250644
[TBL] [Abstract][Full Text] [Related]
15. Targeting apoptosis in the hormone- and drug-resistant prostate cancer cell line, DU-145, by gossypol/zoledronic acid combination.
Sanli UA; Gorumlu G; Erten C; Gul MK; Cengiz E; Kucukzeybek Y; Karaca B; Atmaca H; Uzunoglu S; Karabulut B; Uslu R
Cell Biol Int; 2009 Nov; 33(11):1165-72. PubMed ID: 19716895
[TBL] [Abstract][Full Text] [Related]
16. Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer.
Garikapaty VP; Ashok BT; Chen YG; Mittelman A; Iatropoulos M; Tiwari RK
Oncol Rep; 2005 Jan; 13(1):89-93. PubMed ID: 15583807
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory markers in rats carrying Dunning R3327 H, G, or MAT-LyLu prostatic adenocarcinoma variants.
Rubenstein M; Shaw MW; McKiel CF; Ray PS; Guinan PD
Cancer Res; 1987 Jan; 47(1):178-82. PubMed ID: 3491674
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells.
Oliver CL; Bauer JA; Wolter KG; Ubell ML; Narayan A; O'Connell KM; Fisher SG; Wang S; Wu X; Ji M; Carey TE; Bradford CR
Clin Cancer Res; 2004 Nov; 10(22):7757-63. PubMed ID: 15570010
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase-C gamma-1 (PLCgamma-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells.
Davies G; Martin TA; Ye L; Lewis-Russell JM; Mason MD; Jiang WG
Urol Oncol; 2008; 26(4):386-91. PubMed ID: 18367108
[TBL] [Abstract][Full Text] [Related]
20. Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: II. Secretory membrane activity.
Mycielska ME; Fraser SP; Szatkowski M; Djamgoz MB
J Cell Physiol; 2003 Jun; 195(3):461-9. PubMed ID: 12704656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
